Cargando…
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
BACKGROUND: Venous thromboembolism (VTE) contributes significantly to COVID‐19 morbidity and mortality. The urokinase receptor system is involved in the regulation of coagulation. Levels of soluble urokinase plasminogen activator receptor (suPAR) reflect hyperinflammation and are strongly predictive...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683642/ https://www.ncbi.nlm.nih.gov/pubmed/35924778 http://dx.doi.org/10.1161/JAHA.122.025198 |